Synthetic molecules as DprE1 inhibitors: A patent review.

V. Makarov, G. Manina, K. Mikusova, U. Mollmann, O. Ryabova, B. Saint-Joanis, N. Dhar, M. R. Pasca, S. Buroni, A. P. Lucarelli, A. Milano, E. De Rossi, M. Belanova, A. Bobovska, P. Dianiskova, J. Kordulakova, C. Sala, E. Fullam, P. Schneider, J. D. McKinney, P. Brodin, T. Christophe, S. Waddell, P. Butcher, J. Albrethsen, I. Rosenkrands, R. Brosch, V. Nandi, S. Bharath, S. Gaonkar, R. K. Shandil, V. Balasubramanian, T. Balganesh, S. Tyagi, J. Grosset, G. Riccardi, S. T. Cole, Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis Science. ,vol. 324, pp. 801- 804 ,(2009) , 10.1126/SCIENCE.1171583

Gyanu Lamichhane, Novel targets in M. tuberculosis: search for new drugs Trends in Molecular Medicine. ,vol. 17, pp. 25- 33 ,(2011) , 10.1016/J.MOLMED.2010.10.004

Silvia Buroni, Maria Rosalia Pasca, Ana Luisa de Jesus Lopes Ribeiro, Giulia Degiacomi, Elisabetta Molteni, Giovanna Riccardi, RETRACTED ARTICLE: Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2′-oxidase DprE1: state of art Applied Microbiology and Biotechnology. ,vol. 94, pp. 907- 916 ,(2012) , 10.1007/S00253-012-4013-4

Claudia Trefzer, Monica Rengifo-Gonzalez, Marlon J. Hinner, Patricia Schneider, Vadim Makarov, Stewart T. Cole, Kai Johnsson, Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis Journal of the American Chemical Society. ,vol. 132, pp. 13663- 13665 ,(2010) , 10.1021/JA106357W

Madhavi J. Parekh, Neil W. Schluger, Treatment of latent tuberculosis infection Therapeutic Advances in Respiratory Disease. ,vol. 7, pp. 351- 356 ,(2013) , 10.1177/1753465813503028

Giovanna Riccardi, Maria Rosalia Pasca, Laurent Roberto Chiarelli, Giulia Manina, Andrea Mattevi, Claudia Binda, The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis Applied Microbiology and Biotechnology. ,vol. 97, pp. 8841- 8848 ,(2013) , 10.1007/S00253-013-5218-X

Katarina Miku.sova, Vadim Makarov, Joao Neres, DprE1--from the discovery to the promising tuberculosis drug target. Current Pharmaceutical Design. ,vol. 20, pp. 4379- 4403 ,(2013) , 10.2174/138161282027140630122724

B. Dhahri, H. Aouina, J. Ben Amar, L. El Gharbi, M.A. Baccar, H. Bouacha, S. Azzabi, Revue généraleTraitement de la tuberculoseTuberculosis treatment Revue De Pneumologie Clinique. ,vol. 71, ,(2015) , 10.1016/J.PNEUMO.2014.09.001

Daniel T. Hoagland, Jiuyu Liu, Robin B. Lee, Richard E. Lee, New agents for the treatment of drug-resistant Mycobacterium tuberculosis Advanced Drug Delivery Reviews. ,vol. 102, pp. 55- 72 ,(2016) , 10.1016/J.ADDR.2016.04.026

Ameeruddin Nusrath Unissa, Selvakumar Subbian, Luke Elizabeth Hanna, Nagamiah Selvakumar, Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis Infection, Genetics and Evolution. ,vol. 45, pp. 474- 492 ,(2016) , 10.1016/J.MEEGID.2016.09.004